Molecular and Electrophysiological Analyses of ATP2B4 Gene Variants in Bilateral Adrenal Hyperaldosteronism.
ATP2B3
ATP2B4
Aldosterone
Ca-ATPases
Doxycycline-inducible expression
Primary aldosteronism
Journal
Hormones & cancer
ISSN: 1868-8500
Titre abrégé: Horm Cancer
Pays: United States
ID NLM: 101518427
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
received:
18
08
2019
accepted:
26
12
2019
pubmed:
1
2
2020
medline:
30
9
2020
entrez:
1
2
2020
Statut:
ppublish
Résumé
Primary aldosteronism (PA) is the most common cause of secondary hypertension with a high prevalence among patients with resistant hypertension. Despite the recent discovery of somatic variants in aldosterone-producing adenoma (APA)-associated PA, causes for PA due to bilateral aldosterone production (bilateral hyperaldosteronism; BHA) remain unknown. Herein, we identified rare gene variants in ATP2B4, in a cohort of patients with BHA. ATP2B4 belongs to the same family of Ca-ATPases as ATP2B3, which is involved in the pathogenesis of APA. Endogenous ATP2B4 expression was characterized in adrenal tissue, and the gene variants were functionally analyzed for effects on aldosterone synthase (CYP11B2) expression, steroid production in basal and agonist-stimulated conditions, and for changes in biophysical properties of channel properties. Knockdown of ATP2B4 in HAC15 exhibited reduced angiotensin II stimulation in one of four shRNA clones. Stable HAC15 cell lines with doxycycline (dox) - inducible wild-type and variant forms of ATP2B4 - were generated, and dox-induced upregulation of ATP2B4 mRNA and protein was confirmed. However, ATP2B4 variants did not alter basal or agonist-stimulated CYP11B2 expression. Whole-cell recordings in HAC15 cells indicated robust endogenous ATP2B4 conductance in native cells but reduced conductance with overexpressed WT and variant ATP2B4. The previously defined PA-causing ATP2B3 variant served as a positive control and exhibited elevated CYP11B2 mRNA. In conclusion, while this study did not confirm a pathogenic role for ATP2B4 variants in BHA, we describe the sequencing analysis for familial and sporadic BHA and outline a template for the thorough in vitro characterization of gene variants.
Identifiants
pubmed: 32002807
doi: 10.1007/s12672-019-00375-0
pii: 10.1007/s12672-019-00375-0
pmc: PMC8018534
mid: NIHMS1554279
doi:
Substances chimiques
ATP2B4 protein, human
EC 3.6.1.8
Plasma Membrane Calcium-Transporting ATPases
EC 3.6.3.8
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
52-62Subventions
Organisme : NHLBI NIH HHS
ID : R01 HL130106
Pays : United States
Organisme : NHLBI NIH HHS
ID : 5R01HL130106-04
Pays : United States
Références
Endocrinology. 2016 Jun;157(6):2489-99
pubmed: 27035656
Physiol Rev. 2009 Oct;89(4):1341-78
pubmed: 19789383
Science. 2011 Feb 11;331(6018):768-72
pubmed: 21311022
J Clin Endocrinol Metab. 2012 Aug;97(8):E1532-9
pubmed: 22628607
Protein Sci. 1992 Dec;1(12):1613-21
pubmed: 1339025
PLoS One. 2014 Aug 13;9(8):e104790
pubmed: 25119969
J Clin Endocrinol Metab. 2013 Nov;98(11):E1861-5
pubmed: 24037882
J Clin Endocrinol Metab. 2018 Oct 1;103(10):3869-3876
pubmed: 30085035
Nat Genet. 2018 Mar;50(3):355-361
pubmed: 29403012
Nat Genet. 2013 Apr;45(4):440-4, 444e1-2
pubmed: 23416519
Hypertension. 2019 Apr;73(4):885-892
pubmed: 30739536
J Biol Chem. 1992 Mar 5;267(7):4376-85
pubmed: 1531651
J Mol Endocrinol. 2016 Jul;57(1):1-11
pubmed: 27099398
Brain Behav. 2015 Apr;5(4):e00321
pubmed: 25798335
EBioMedicine. 2016 Nov;13:225-236
pubmed: 27729216
Endocrinology. 2015 Jul;156(7):2530-40
pubmed: 25868050
Nat Genet. 2018 Mar;50(3):349-354
pubmed: 29403011
J Biol Chem. 2003 Sep 12;278(37):35798-804
pubmed: 12829699
J Clin Endocrinol Metab. 2014 Sep;99(9):E1765-73
pubmed: 25057880
Nat Genet. 2013 Sep;45(9):1050-4
pubmed: 23913001
J Biol Chem. 1994 Jan 7;269(1):41-3
pubmed: 8276828
J Biol Chem. 1993 Dec 5;268(34):25993-6003
pubmed: 8245032
Elife. 2015 Apr 24;4:e06315
pubmed: 25907736
Nat Genet. 2013 Sep;45(9):1055-60
pubmed: 23913004
Physiol Rev. 2001 Jan;81(1):21-50
pubmed: 11152753
Mol Cell Endocrinol. 2006 May 16;250(1-2):93-7
pubmed: 16442703
Hypertension. 2012 Feb;59(2):235-40
pubmed: 22203740
J Biol Chem. 2017 Dec 22;292(51):21047-21059
pubmed: 29042438
PLoS One. 2009 Aug 06;4(8):e6529
pubmed: 19657394
J Hypertens. 2012 Sep;30(9):1827-33
pubmed: 22743686
Hum Gene Ther. 2011 Oct;22(10):1255-67
pubmed: 21761975
Endocrinology. 2012 Apr;153(4):1774-82
pubmed: 22315453
PLoS One. 2012;7(7):e41926
pubmed: 22848660
J Clin Endocrinol Metab. 2012 Aug;97(8):E1567-72
pubmed: 22628608
Biochem J. 1995 Mar 15;306 ( Pt 3):779-85
pubmed: 7702574
J Biol Chem. 1991 Feb 15;266(5):2930-6
pubmed: 1847139
Genomics. 1991 Apr;9(4):629-41
pubmed: 1674727
Biochim Biophys Acta. 2011 May;1813(5):974-8
pubmed: 21167220
Hypertension. 2012 Mar;59(3):587-91
pubmed: 22252394
Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2533-8
pubmed: 22308486
Biochem J. 1994 Oct 1;303 ( Pt 1):275-9
pubmed: 7945253
Hypertension. 2018 Oct;72(4):874-880
pubmed: 30354720
Hypertension. 2014 Aug;64(2):354-61
pubmed: 24866132